TIL Cells
Showing 1 - 25 of >10,000
Solid Tumor Trial (Tumor Infiltrating Lymphocytes, Fludarabine, Cyclophosphamide Capsules)
Not yet recruiting
- Solid Tumor
- Tumor Infiltrating Lymphocytes
- +3 more
- (no location specified)
Dec 11, 2022
Advanced Pancreatic Cancer Trial in Nanjing (Adoptive TIL-TCM transfer therapy)
Recruiting
- Advanced Pancreatic Cancer
- Adoptive TIL-TCM transfer therapy
-
Nanjing, Jiangsu, ChinaJinling Hospital
Jun 29, 2022
HNSCC, Melanoma, Gynecologic Cancer Trial in Portland (DP CD8 TIL, DP CD8 TIL KD, Low dose IL-2)
Recruiting
- HNSCC
- +5 more
- DP CD8 TIL
- +2 more
-
Portland, OregonProvidence Portland Medical Center
Jun 5, 2023
HPV-Associated Cervical Carcinoma, HPV-Related Carcinoma, HPV-Related Malignancy Trial in New Brunswick (Conditioning, E7 TCR-T
Not yet recruiting
- HPV-Associated Cervical Carcinoma
- +16 more
- Conditioning, E7 TCR-T cells, and aldesleukin
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Jan 17, 2023
NSCLC Trial in Zhengzhou (L-TIL, Tislelizumab, Docetaxel)
Recruiting
- Non-small Cell Lung Cancer
- L-TIL, Tislelizumab, Docetaxel
-
Zhengzhou, Henan, ChinaNo.127 Dongming Road
May 17, 2023
Non Small Cell Lung Cancer, Stage IV NSCLC, Recurrent Non Small Cell Lung Cancer Trial in Tampa (biological, drug, other)
Recruiting
- Non Small Cell Lung Cancer
- +2 more
- Tumor-infiltrating Lymphocytes (TIL)
- +5 more
-
Tampa, FloridaMoffitt Cancer Center
Dec 28, 2022
Stage III Cutaneous Melanoma AJCC v7, Stage IIIA Cutaneous Melanoma AJCC v7, Stage IIIB Cutaneous Melanoma AJCC v7 Trial in
Completed
- Stage III Cutaneous Melanoma AJCC v7
- +5 more
- Aldesleukin
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2022
Metastatic Colorectal Cancer, Metastatic Pancreatic Cancer, Metastatic Ovarian Cancer Trial run by the National Cancer Institute
Recruiting
- Metastatic Colorectal Cancer
- +4 more
- Young TIL
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 25, 2023
Metastatic Melanoma Trial run by the National Cancer Institute (NCI) (Aldesleukin, Fludarabine, Cyclophosphamide)
Completed
- Metastatic Melanoma
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Dec 21, 2022
Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating
Recruiting
- Urothelial Carcinoma
- Non-Invasive Bladder Urothelial Carcinoma
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
-
Tampa, FloridaMoffitt Cancer Center
Mar 2, 2023
Metastatic Melanoma, Unresectable Melanoma, Acral Melanoma Trial in Tampa (TBio-4101, Cyclophosphamide, Fludarabine)
Recruiting
- Metastatic Melanoma
- +9 more
- TBio-4101
- +3 more
-
Tampa, FloridaMoffitt Cancer Center
Jan 24, 2023
Solid Tumor Trial in Shanghai (BEN101)
Not yet recruiting
- Solid Tumor
- BEN101
-
Shanghai, Shanghai, China
- +1 more
Apr 14, 2023
NSCLC, Metastatic Non Small Cell Lung Cancer, Stage IV NSCLC Trial in Duarte, Minneapolis (Fludarabine, Cyclophosphamide, CISH
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- +5 more
- Fludarabine
- +4 more
-
Duarte, California
- +1 more
Dec 7, 2022
Metastatic Melanoma Trial in Tampa (procedure, drug, other)
Active, not recruiting
- Metastatic Melanoma
- Surgery
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
Jan 10, 2023
Toxicity, Drug, Adverse Drug Event, Effects of Immunotherapy Trial in Leiden (Nivolumab & Tumor Infiltrating Lymphocytes
Recruiting
- Toxicity, Drug
- +2 more
- Nivolumab & Tumor Infiltrating Lymphocytes with/without Interferon-Alpha
-
Leiden, NetherlandsLeiden University Medical Center
Aug 16, 2022
Metastatic Non Small Cell Lung Cancer Trial in Raleigh (C-TIL051)
Not yet recruiting
- Metastatic Non Small Cell Lung Cancer
- C-TIL051
-
Raleigh, North CarolinaDuke Cancer Institute
Jan 6, 2023
Triple Negative Breast Cancer, Breast Cancer Trial in United States (Carboplatin, Docetaxel, Doxorubicin)
Recruiting
- Triple Negative Breast Cancer
- Breast Cancer
- Carboplatin
- +4 more
-
Fairway, Kansas
- +5 more
Jan 26, 2023
Uveal Tumors, Melanoma, Uveal Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL))
Recruiting
- Uveal Neoplasms
- Melanoma, Uveal
- Tumor Infiltrating Lymphocytes (TIL)
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
pCR After Neoadjuvant Therapy in Breast Cancer Patients
Recruiting
- Breast Cancer
- TIL assessment in pre-existing histopathological specimens
-
Cairo, EgyptFaculty of Medicine, Ain Shams University
Jul 25, 2022
Metastatic Melanoma, Skin Cancer Trial run by the National Cancer Institute (NCI) (drug, biological, radiation)
Active, not recruiting
- Metastatic Melanoma
- Skin Cancer
- Aldesleukin
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Aug 24, 2022
Metastatic Melanoma Trial in New Haven (Tumor Infiltrating Lymphocytes, Nivolumab and Ipilimumab)
Terminated
- Metastatic Melanoma
- Tumor Infiltrating Lymphocytes
- Nivolumab and Ipilimumab
-
New Haven, ConnecticutYale New Haven Hospital
Jul 20, 2022
Gastric Cancer, Colorectal Cancer, Pancreatic Cancer Trial in Pittsburgh (Tumor Infiltrating Lymphocytes (TIL), Fludarabine +
Recruiting
- Gastric Cancer
- +9 more
- Tumor Infiltrating Lymphocytes (TIL)
- Fludarabine + Cyclophosphamide combination
-
Pittsburgh, PennsylvaniaUPMC Hillman Cancer Center
Jul 21, 2022
Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8 Trial in
Not yet recruiting
- Clinical Stage IV Cutaneous Melanoma AJCC v8
- +3 more
- Biospecimen Collection
- +8 more
-
Kansas City, KansasUniversity of Kansas Cancer Center
Nov 27, 2023